Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...
Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...
The vision of one child with AIPL1-associated severe retinal dystrophy improved from light perception to naming his favourite ...
A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic ...
An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...
MeiraGTx Holdings plc announced promising results from a first-in-human study published in The Lancet, involving a gene therapy treatment for children with AIPL1-associated retinal dystrophy ...
British scientists have become the first in the world to use a pioneering gene therapy to preserve sight in toddlers with the ...
Children administered with gene therapy can now see shapes, find toys, and read and write after world-first treatment ...
7don MSN
A Connecticut boy is among four children all born with severe childhood blindness who gained “life-changing improvements” to ...
The AAV-AIPL1 therapy is designed to address severe sight impairment caused by mutations in the AIPL1 gene. This condition is a form of retinal dystrophy that leads to severe visual impairment ...
Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results